99
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

In vitro and in vivo pharmacokinetics of two novel 1,3-cyclic propanyl phosphate ester prodrugs of 18β-glycyrrhetic acid in rats

, , , &
Pages 879-893 | Received 11 Apr 2010, Accepted 11 Jul 2010, Published online: 28 Sep 2010
 

Abstract

The in vitro metabolism of two novel phosphate prodrugs of glycyrrhetic acid (GA) was studied by the method of incubation in the rat liver microsome and the in vivo plasma pharmacokinetics after injecting intravenously (i.v.) into six rats was investigated, respectively. The prodrugs diminished gradually with time and most of the parent drugs were released in 30 min in vitro. In this paper, the in vivo plasma concentration data were analyzed by compartmental modeling. Both the prodrugs and the corresponding released parent drugs could be described by a two-compartment model, which existed for 48 h in rats. The t 1/2 increases remarkably after i.v. administration to rats when compared with injecting the parent drugs directly.

Acknowledgements

We are grateful to Mr Wei-Zhi Sun (Key Laboratory of Marine Drugs, Ministry of Education, Marine Drug and Food Institute, Ocean University of China) for the preparation of samples. We also gratefully acknowledge Ms Xiu-Li Zhang and Su-Mei Ren (Key Laboratory of Marine Drugs, Ministry of Education, Marine Drug and Food Institute, Ocean University of China) for the measurement of ESI-TOF-MS and NMR spectra, respectively.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.